D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4176
Infinite Eagle Acquisition Corp Rights
IEAGR
| $113K | ﹤0.01% |
+625,000
| New | +$118K |
2026 Q1
0 quarters
|
|
4177
Sana Biotechnology
SANA
$721M
| $111K | ﹤0.01% |
38,670
-22,230
| -37% | -$87.6K |
2025 Q4
1 quarter
|
|
4178
Agenus
AGEN
$314M
| $111K | ﹤0.01% |
33,269
-94,369
| -74% | -$313K |
2025 Q3
2 quarters
|
|
4179
SoundThinking
SSTI
$109M
| $108K | ﹤0.01% |
16,275
-12,778
| -44% | -$93.4K |
2024 Q2
7 quarters
|
|
4180
Avino Silver & Gold Mines
ASM
$883M
| $107K | ﹤0.01% |
+16,900
| New | +$135K |
2026 Q1
0 quarters
|
|
4181
CVRx
CVRX
$36.2M
| $106K | ﹤0.01% |
11,229
-84,983
| -88% | -$622K |
2022 Q4
13 quarters
|
|
4182
CALL
Organon & Co
OGN
$3.62B
| $105K | ﹤0.01% |
17,600
| – | – |
2025 Q3
2 quarters
|
|
4183
PUT
Array Technologies
ARRY
$550M
| $105K | ﹤0.01% |
14,500
-233,300
| -94% | -$2.16M |
2024 Q2
7 quarters
|
|
4184
GCT Semiconductor Holding Warrants
GCTS.WS
$13.5M
| $104K | ﹤0.01% |
575,000
| – | – |
2022 Q1
16 quarters
|
|
4185
Exagen
XGN
$205M
| $104K | ﹤0.01% |
34,569
+2,990
| +9% | +$11.6K |
2025 Q4
1 quarter
|
|
4186
PUT
Graphic Packaging
GPK
$2.49B
| $99.4K | ﹤0.01% |
+10,000
| New | +$126K |
2026 Q1
0 quarters
|
|
4187
Soren Acquisition Corp Warrant
SORNW
| $98.7K | ﹤0.01% |
+308,333
| New | +$94K |
2026 Q1
0 quarters
|
|
4188
DELISTED
AtaiBeckley Inc
ATAI
| $97.1K | ﹤0.01% |
27,419
-237,098
| -90% | -$893K |
2024 Q4
5 quarters
|
|
4189
Phreesia
PHR
$667M
| $96.7K | ﹤0.01% |
+11,541
| New | +$153K |
2026 Q1
0 quarters
|
|
4190
ARS Pharmaceuticals
SPRY
$403M
| $95.3K | ﹤0.01% |
11,873
-14,654
| -55% | -$140K |
2024 Q1
8 quarters
|
|
4191
Churchill Capital Corp XI Warrants
CCXIW
$20.7M
| $94K | ﹤0.01% |
+129,718
| New | +$103K |
2026 Q1
0 quarters
|
|
4192
Helport AI Warrants
HPAIW
$379K
| $93.2K | ﹤0.01% |
847,500
| – | – |
2024 Q3
6 quarters
|
|
4193
New Era Energy & Digital Inc Warrants
NUAIW
$13.9M
| $91K | ﹤0.01% |
49,999
| – | – |
2024 Q4
5 quarters
|
|
|
LOKVW
4194
DELISTED
Live Oak Acquisition Corp V Warrants
LOKVW
| $90.6K | ﹤0.01% |
62,500
| – | – |
2025 Q2
3 quarters
|
|
4195
KRAKacquisition Corp Warrants
KRAQW
$3.36M
| $90K | ﹤0.01% |
+150,000
| New | +$106K |
2026 Q1
0 quarters
|
|
4196
Granite Ridge Resources
GRNT
$671M
| $85.7K | ﹤0.01% |
+14,603
| New | +$73.3K |
2026 Q1
0 quarters
|
|
4197
Microvast
MVST
$214M
| $85.7K | ﹤0.01% |
57,114
+36,302
| +174% | +$87.4K |
2025 Q3
2 quarters
|
|
4198
Lifezone Metals Ltd Warrants
LZM.WS
| $83.2K | ﹤0.01% |
166,366
| – | – |
2023 Q3
10 quarters
|
|
4199
Pyrophyte Acquisition Corp II Warrants
PAII.WS
| $82.5K | ﹤0.01% |
250,000
| – | – |
2025 Q3
2 quarters
|
|
4200
Empery Digital
EMPD
$98M
| $82.2K | ﹤0.01% |
+19,432
| New | +$84.1K |
2026 Q1
0 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.